Product information and disease descriptionProduct descriptionProduct informationPharmacology
Pharmacokinetics
4 evidence topics · 4 sources
Dose proportionality, half-life, and renal clearance in healthy adults
“The PK of inaxaplin was generally dose proportional, and the variability in PK parameters was generally low and did not appear to change across the dose range (online Table S1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Half-life was consistent across both studies ranging from approximately 13.3 to 22.9 h, which supports once daily dosing (online Table S1).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Renal clearance was a minor excretion pathway for inaxaplin” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote